Fifth Third Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Fifth Third Wealth Advisors's NVO Position: Q3 2026 in Review
Fifth Third Wealth Advisors increased its Novo Nordisk (NVO) stake by 23% in Q3 2026, buying an estimated $51.6K and bringing the position to 6,068 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #925.
Fifth Third Wealth Advisors first reported a position in NVO in Q2 2024 and has held it in 10 quarters since. The position peaked at $436K in Q3 2024. 1,110 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Fifth Third Wealth Advisors held 6,068 shares of Novo Nordisk worth $230K as of Q3 2026.
- Fifth Third Wealth Advisors bought 1,120 Novo Nordisk shares in Q3 2026, an estimated $51.6K.
- Novo Nordisk made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #925 holding.
- Fifth Third Wealth Advisors first reported a position in Novo Nordisk in Q2 2024 and has held it in 10 quarters since.
- Fifth Third Wealth Advisors's Novo Nordisk position peaked at $436K in Q3 2024.
- 1,110 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.